引用次数
引用: 40,448
H-指数: 103
I10-指数 : 362
出版物: 597
Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate
M Anafi , A Gazit , A Zehavi , Y Ben-Neriah
Blood 82 ( 12) 3524 -3529
129
1993
Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
J E Sevransky , G Shaked , A Novogrodsky , A Levitzki
Journal of Clinical Investigation 99 ( 8) 1966 -1973
48
1997
Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
J C López-Talavera , A Levitzki , M Martínez , A Gazit
Journal of Clinical Investigation 100 ( 3) 664 -670
49
1997
Anti-Cdc25 antibodies inhibit guanyl nucleotide-dependent adenylyl cyclase of Saccharomyces cerevisiae and cross-react with a 150-kilodalton mammalian protein.
E Gross , I Marbach , D Engelberg , M Segal
Molecular and Cellular Biology 12 ( 6) 2653 -2661
21
1992
Preparation and characterization of hormone-sensitive, resealed erythrocyte ghosts.
M L Steer , C Baldwin , A Levitzki
Journal of Biological Chemistry 251 ( 16) 4930 -4935
8
1976
Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor.
S E Winograd-Katz , A Levitzki
Oncogene 25 ( 56) 7381 -7390
197
2006
The control of adenylate cyclase by calcium in turkey erythrocyte ghosts.
ML Steer , A Levitzki
Journal of Biological Chemistry 250 ( 6) 2080 -2084
126
1975
The activation of adenylate cyclase by guanyl nucleotides in Saccharomyces cerevisiae is controlled by the CDC25 start gene product.
Jacques Daniel , Jeffrey M Becker , Elizabeth Enari , Alexander Levitzki
Molecular and Cellular Biology 7 ( 10) 3857 -3861
44
1987
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors
A Novogrodsky , A Vanichkin , M Patya , A Gazit
Science 264 ( 5163) 1319 -1322
330
1994
Abstract PD2-07: Insulin receptor substrate (IRS) targeting by the tyrophostin NT157 inhibits breast cancer cell growth
D Yee , NA Temiz , A Levitzki , Y Yang
Cancer Research 76
2016
GTP-GDP exchange proteins.
A Levitzki
Science 248 ( 4957) 794 -794
5
1990
Tyrosine kinase inhibition: an approach to drug development
A Levitzki , A Gazit
Science 267 ( 5205) 1782 -1788
2,124
1995
From epinephrine to cyclic AMP.
A Levitzki
Science 241 ( 4867) 800 -806
227
1988
Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.
R M Lyall , A Zilberstein , A Gazit , C Gilon
Journal of Biological Chemistry 264 ( 24) 14503 -14509
282
1989
Interaction between the Saccharomyces cerevisiae CDC25 gene product and mammalian ras.
M Segal , I Marbach , D Engelberg , G Simchen
Journal of Biological Chemistry 267 ( 32) 22747 -22751
5
1992
Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor
SE Winograd-Katz , A Levitzki , MA Hahn , DJ Marsh
Oncogene 26 ( 5) 788 -788
2007
Improved synthesis of backbone and macrocyclic peptides: application to PKB, gp120 and integrase inhibitors
A Gilon , Y Tal-Gan , S Jubran , Y Barda
JOURNAL OF PEPTIDE SCIENCE 16 76 -76
2010
International Journal of Experimental and Clinical Pharmacology
KF Sewing , HK Heim , AP Alvares , LZ Benet
Pharmacology 51
1995
KARG Eil
KF Sewing , JD Connor Hershey , Pa H-K Heim , WB Severs
Pharmacology 52
1996
Bioorganic chemistry of biological signal transduction
György Dorman , PJ Hergenrother , C Herrmann , J Kuhlmann
Springer 211
6
2003